Key result
Stopping anticoagulation at six months for unprovoked submassive PE highlights the long-term VTE risk dilemma.
Key points are not available for this paper at this time.
Population
One previously healthy 47-year-old woman with submassive pulmonary embolism
Design
Case report
Answers are grounded in this paper and cite their sources.
Individualized anticoagulation decisions remain essential post-unprovoked submassive PE; leaves open optimal duration in women.
A previously healthy 47-year-old woman was started on anticoagulant therapy six months ago. She had been diagnosed with a submassive pulmonary embolism after returning from a trip to the Caribbean. At that time, she had no associated deep vein thrombosis on ultrasonography and her symptoms have
No takes yet. Share an insight, caveat, or question.
Khan et al. (2017) studied this question. Stopping anticoagulation after six months in a woman with unprovoked submassive pulmonary embolism highlights the clinical dilemma of managing long-term venous thromboembolism risk.
Synapse has enriched 10 related papers. Consider them for comparative context: